Being a leading pharmaceutical company and growing every year, Glenmark has had to continuously invest in manufacturing capacity to meet growing demand for its products. The company has five manufacturing facilities.

Three manufacturing facilities are in India i.e. One manufacturing facility in Nasik, Maharashtra and two facilities in Baddi, Himachal Pradesh. Glenmark also has a manufacturing facility in the Czech Republic which services requirements of the Central Eastern Europe region and another in Brazil which services the Latin American region.

All these manufacturing facilities are not only WHO-GMP compliant but are also approved by regulatory bodies of respective countries. The facility in Baddi is also approved by MHRA(UK) and the FDA(US) for semi-solids. The Czech facility is EU-GMP compliant while the Nasik facility has approvals from several regulatory authorities including Anvisa(Brazil), MCC etc